Dendritic cells loaded with FK506 kill T cells in an antigen-specific manner and prevent autoimmunity in vivo

FK506 (Tacrolimus) is a potent inhibitor of calcineurin that blocks IL2 production and is widely used to prevent transplant rejection and treat autoimmunity. FK506 treatment of dendritic cells (FKDC) limits their capacity to stimulate T cell responses. FK506 does not prevent DC survival, maturation, or costimulatory molecule expression, suggesting that the limited capacity of FKDC to stimulate T cells may be due to inhibition of calcineurin signaling in the DC. Instead, we demonstrate that DC inhibit T cells by sequestering FK506 and continuously releasing the drug over several days. T cells encountering FKDC proliferate but fail to upregulate the survival factor bcl-xl and die, and IL2 restores both bcl-xl and survival. In mice, FKDC act in an antigen-specific manner to inhibit T-cell mediated autoimmune arthritis. This establishes that DCs can act as a cellular drug delivery system to target antigen specific T cells. DOI: http://dx.doi.org/10.7554/eLife.00105.001

[1]  Zhiliang Wang,et al.  Rapamycin-Conditioned Dendritic Cells Are Poor Stimulators of Allogeneic CD4+ T Cells, but Enrich for Antigen-Specific Foxp3+ T Regulatory Cells and Promote Organ Transplant Tolerance1 , 2007, The Journal of Immunology.

[2]  R. Darnell,et al.  Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-α/β on antigen cross-presentation , 2007 .

[3]  Motohiko Suzuki,et al.  Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine , 2006, Arthritis research & therapy.

[4]  S. Goerdt,et al.  Immunosuppressive agents mediate reduced allostimulatory properties of myeloid-derived dendritic cells despite induction of divergent molecular phenotypes. , 2005, Molecular immunology.

[5]  S. Eo,et al.  Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells. , 2005, Blood.

[6]  R. Darnell,et al.  Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy , 2004, Prostate Cancer and Prostatic Diseases.

[7]  A. Strasser,et al.  Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. , 2002, Immunity.

[8]  P. Mandrekar,et al.  Tacrolimus and Cyclosporine A Inhibit Allostimulatory Capacity and Cytokine Production of Human Myeloid Dendritic Cells , 2001, Journal of Investigative Medicine.

[9]  J. D. de Fijter,et al.  The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. , 2000, European journal of immunology.

[10]  K. Migita,et al.  FK506 markedly enhances apoptosis of antigen-stimulated peripheral T cells by down-regulation of Bcl-xL. , 1999, Transplantation.

[11]  A. Bendele,et al.  Animal Models of Arthritis: Relevance to Human Disease , 1999, Toxicologic pathology.

[12]  M. Albert,et al.  Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs , 1998, Nature.

[13]  R. Steinman,et al.  Isolation of Dendritic Cells , 1998, Current protocols in immunology.

[14]  R. Steinman,et al.  Isolation of Dendritic Cells , 1998, Current protocols in immunology.

[15]  K. Oka,et al.  Tacrolimus-induced apoptosis and its prevention by interleukins in mitogen-activated human peripheral-blood mononuclear cells. , 1998, Immunopharmacology.

[16]  S. Nagataki,et al.  FK506 potentiates steroid-induced T-cell apoptosis. , 1997, Transplantation.

[17]  Edward F. Rosloniec,et al.  Collagen‐Induced Arthritis , 1996, Current protocols in immunology.

[18]  John Calvin Reed,et al.  Interleukin‐2 receptor common γ‐chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti‐apoptotic (bcl‐2, bcl‐xL) but not pro‐apoptotic (bax, bcl‐xS) gene expression , 1996, European journal of immunology.

[19]  S. Nagataki,et al.  FK506 augments activation-induced programmed cell death of T lymphocytes in vivo. , 1995, The Journal of clinical investigation.

[20]  Tetsuhide Ito,et al.  Protective effects of gabexate mesilate on acute pancreatitis induced by tacrolimus (FK-506) in rats in which the pancreas was stimulated by caerulein , 1994, Journal of Gastroenterology.

[21]  G. Prud’homme,et al.  Cyclosporin A markedly enhances superantigen-induced peripheral T cell deletion and inhibits anergy induction , 1992, The Journal of experimental medicine.

[22]  A. Tangoku,et al.  Effects of FK506 on Exocrine Pancreas in Rats , 1992, Pancreas.

[23]  L A Herzenberg,et al.  Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Todo,et al.  Species differences in sensitivity of T lymphocytes to immunosuppressive effects of FK 506. , 1990, Transplantation.

[25]  Nolan H. Sigal,et al.  A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin , 1989, Nature.

[26]  N. Sigal,et al.  FK-506, a potent novel immunosuppressive agent, binds to a cytosolic protein which is distinct from the cyclosporin A-binding protein, cyclophilin. , 1989, Journal of immunology.

[27]  T. Hotokebuchi,et al.  Effects of FK-506 on collagen arthritis in mice. , 1989, Transplantation proceedings.

[28]  Imrie Rc.  Animal models of arthritis. , 1976 .

[29]  N. Bhardwaj,et al.  Directing dendritic cell immunotherapy towards successful cancer treatment. , 2010, Immunotherapy.

[30]  R. Darnell,et al.  Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-alpha/beta on antigen cross-presentation. , 2007, Blood.

[31]  A. Thomson,et al.  Dendritic cells: emerging pharmacological targets of immunosuppressive drugs , 2004, Nature Reviews Immunology.

[32]  F. Dumont,et al.  Quantitative and temporal analysis of the cellular interaction of FK-506 and rapamycin in T-lymphocytes. , 1994, The Journal of pharmacology and experimental therapeutics.

[33]  M. Lenardo.  Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. , 1991, Nature.

[34]  W. J. Cromartie,et al.  Radiologic analysis of arthritis in rats after systemic injection of streptococcal cell walls. , 1979, Arthritis and rheumatism.

[35]  R. C. Imrie.  Animal models of arthritis. , 1976, Laboratory animal science.